• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 877

Bifidobacterium longum BB536

Intended Use: Intended for use as an ingredient in term infant formula at a level of 1 x 108 CFU per gram of product.
Basis: Scientific procedures
Notifier: Morinaga Milk Industry Co., Ltd.
Notifier Address: 331, Shiba 5-Chrome, Minato-ku
Tokyo, Japan 108-8384
GRAS Notice (releasable information): GRN 877 (in PDF) (5.2 MB)
Date of closure: Dec 26, 2019
FDA's Letter: FDA has no questions (in PDF) (75 KB)